Irhythm Technologies, Inc. Investors: Please Contact The Portnoy Law Firm To Recover Your Losses; April 8, 2024 Deadline


(MENAFN- GlobeNewsWire - Nasdaq) Investors can contact the law firm at no cost to learn more about recovering their losses

LOS ANGELES, April 08, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises iRhythm Technologies, Inc. (NASDAQ: IRTC) investors that a lawsuit was filed on behalf of investors that purchased iRhythm securities between January 11, 2022 and May 30, 2023, 2023, inclusive (the“Class Period”).

Investors are encouraged to contact attorney Lesley F. Portnoy , by phone 310-692-8883 or email : ..., to discuss their legal rights, or click here to join the case via . The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to recover their losses.

The iRhythm class action lawsuit accuses the company of making false and misleading statements or failing to disclose non-compliance with FDA marketing regulations and not reporting adverse events as required, all while promoting its heart monitoring devices for unapproved uses. The lawsuit outlines a series of events where iRhythm revised its revenue guidance downwards and issued a Customer Advisory Notice due to concerns raised by the FDA, leading to a drop in its stock price. Additionally, the company faced scrutiny from the FDA and the U.S. Department of Justice, leading to further stock price declines after the disclosure of a subpoena and a warning letter concerning regulatory non-conformities and quality system requirements related to its Zio AT System.

Please visit our website to review more information and submit your transaction information.

The Portnoy Law Firm represents investors in pursuing claims caused by corporate wrongdoing. The Firm's founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.

Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
...
310-692-8883

Attorney Advertising


MENAFN08042024004107003653ID1108073237


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.